Whitepaper: Planning for every eventuality

With over 6 billion doses ordered across the globe as of December 2020*, the vaccine rollout will be a monumental effort. Besides the existing concerns about the logistical implications of this program, the impact it will have on “business as usual” clinical trials and pharma distribution could worry organizations who require capacity for their own products.

Download this whitepaper to learn more about:

• The temperature control requirement for COVID-19 vaccines
• The status of global supply channels
• How to maintain the integrity of your clinical trials and deliver the life-changing treatments your patients need

*Seabury Consulting analysis (December 2020)